80339 Munich, Germany
Phone: +49 (0)89 500 941-0
Fax: +49 (0)89 500 941-29
Silantes uses a new technology to produce biomolecules such as amino acids, nucleotides, peptides, proteins and DNA. The company has a staff of highly skilled scientists from the fields of molecular biology, microbiology, biochemistry and biotechnology who can provide flexible, intelligent and customer-oriented responses to the needs of science and industry.
Silantes was founded in 1998 by a researcher from the German Max-Planck-Institute, who developed a new method for the production of stable isotope labeled biomolecules based on chemolithoautotrophic bacteria (patent pending). This technology exploits the fact that chemolithoautotrophic bacteria can metabolise inorganic carbon in a pathway similar to that of green plants. Chemolithoautotrophic bacteria combine the advantage of green plants of being able to assimilate CO2 with the advantages of bacteria of being more productive and reliable as well as capable of expressing heterologous proteins.